Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Robin Wijsman - , Radboud University Medical Center (Author)
  • Willem Grootjans - , Radboud University Medical Center (Author)
  • Esther G. Troost - , Department of Radiotherapy and Radiooncology, OncoRay - National Center for Radiation Research in Oncology, Helmholtz-Zentrum Dresden-Rossendorf, University Hospital Carl Gustav Carus Dresden (Author)
  • Erik H. Van Der Heijden - , Radboud University Medical Center (Author)
  • Eric P. Visser - , Radboud University Medical Center (Author)
  • Lioe Fee De Geus-Oei - , Leiden University, University of Twente (Author)
  • Johan Bussink - , Radboud University Medical Center (Author)

Abstract

Objective This radiotherapy planning study evaluated tumour delineation using both optimally respiratory gated and nongated fluorine-18 fluorodeoxyglucose-PET (18F-FDG-PET). Methods For 22 non-small-cell lung tumours, both scans were used to create the nongated and gated (g) gross tumour volumes (GTVg) together with the accompanying clinical target volumes (CTV) and planning target volumes (PTV). The size of the target volumes (TV) was evaluated and the accompanying radiotherapy plans were created to study the radiation doses to the organs at risk (OAR). Results The median volumes of GTVg, CTVg and PTVg were statistically significantly smaller compared with the corresponding nongated volumes, resulting in a median TV reduction of 0.5 cm3 (interquartile range 0.1-1.2), 1.5 cm3 (-0.2 to 7.0) and 2.3 cm3 (-0.5 to 11.3) for the GTVg, CTVg and PTVg, respectively. For the OAR, only the percentage of lung (GTV included) receiving at least 35 Gy was significantly smaller after gating, with a median difference in lung volume receiving at least 35 Gy of 5.7 cm3 (interquartile range -0.8 to 30.50). Conclusion Compared with nongated 18F-FDG-PET, the TVs obtained with optimally respiratory gated 18F-FDG-PET were significantly smaller, however, without a clinically relevant difference in radiation dose to the OAR.

Details

Original languageEnglish
Pages (from-to)66-73
Number of pages8
JournalNuclear medicine communications
Volume37
Issue number1
Publication statusPublished - 2016
Peer-reviewedYes

External IDs

PubMed 26440570

Keywords

Sustainable Development Goals

Keywords

  • 18F-FDG-PET, non-small-cell lung cancer, radiotherapy, respiratory gating